4d Molecular Therapeutics In shares owned by Hanson McClain Advisors
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Hanson McClain Advisors
from 13F filings
Historical chart of Hanson McClain Advisors investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in 4d Molecular Therapeutics In by Hanson McClain Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $893 | 28 | 31.89 |